Student left with keloid scar after ear piercing as an act of teenage rebellion
18-year-old Remmie was left with a hazelnut-sized keloid scar on her ear after a bar piercing went badly wrong. The teen, who says she had hoped to stand out of the crowd, describes the scar as 'vile'. (Source: the Mail online | Health)
Source: the Mail online | Health - April 24, 2015 Category: Consumer Health News Source Type: news
Your NEJM Group Today: Incisional Keloid, Being Taught to Teach, Washington IM Opportunity (FREE)
By The Editors
NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:NEJM Clinical Practice Center: … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - April 13, 2015 Category: Primary Care Source Type: news
Gene may open door for improved keloid, scar treatment
A gene that may offer a better understanding of how keloid scars develop has been discovered, potentially opening the door to improved treatment for the often painful, itchy and tender scars. The study is the first to demonstrate that an altered AHNAK gene may have a significant biological role in keloid development. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 23, 2015 Category: Science Source Type: news
Gene may open door for improved keloid, scar treatment
(Henry Ford Health System) Researchers at Henry Ford Hospital in Detroit have identified a gene that may offer a better understanding of how keloid scars develop and potentially open the door to improved treatment for the often painful, itchy and tender scars. The study is the first to demonstrate that an altered AHNAK gene may have a significant biological role in keloid development. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 23, 2015 Category: Global & Universal Source Type: news
Breakthrough drug-eluting patch stops scar growth, reduces scar tissues
A new invention provides a simple, affordable and -- most importantly -- highly effective way for patients to self-treat keloid scars. It is a special patch made from polymers fabricated into microneedles, which are loaded with the US FDA-approved scar-reducing drug, 5-fluorouracil. Self-administered by patients, the microneedles attach the patch to scar tissue and allow sustained drug-release. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 23, 2014 Category: Science Source Type: news
Keloid development: New genes identified may unlock its mystery
Previously unidentified genes that may be responsible for keloid scarring have been uncovered by researchers, a discovery that could unlock the mystery of keloid development and provide insight for more effective treatment. Keloid scars form raised, firm skin areas that may become itchy, tender, and painful. Unlike regular scars, keloids do not subside over time and often extend outside the wound site. Keloids most often occur on the chest, shoulders, earlobes (following ear piercing), upper arms and cheeks. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 29, 2014 Category: Science Source Type: news
Study: New genes identified may unlock mystery of keloid development
(Henry Ford Health System) Researchers at Henry Ford Hospital in Detroit have uncovered previously unidentified genes that may be responsible for keloid scarring, a discovery that could unlock the mystery of keloid development and provide insight for more effective treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 29, 2014 Category: Global & Universal Source Type: news
Keloid Associated With Ear Piercing
This is a classic keloidal mass, which occur in any ethic group. Because keloids can be intensely painful, they almost always require removal. (Source: Consultant Live)
Source: Consultant Live - May 2, 2013 Category: Primary Care Source Type: news
RXi completes enrolment in second Phase I trial of anti-scarring drug
Biotechnology company RXi Pharmaceuticals has announced the completion of enrolment in the second Phase I trial of RXI-109, to manage surgical and hypertrophic scars and keloids. (Source: Drug Development Technology)
Source: Drug Development Technology - February 1, 2013 Category: Pharmaceuticals Source Type: news
